Clinical and Experimental Hepatology

metrics 2024

Exploring the Frontiers of Liver Disease Management

Introduction

Clinical and Experimental Hepatology is a pivotal journal dedicated to advancing the field of hepatology, providing a platform for researchers, clinicians, and students to disseminate and explore groundbreaking findings. Published by TERMEDIA PUBLISHING HOUSE LTD in Poland, this journal serves as a vital resource for professionals seeking to enhance their knowledge and contributions in the realm of liver diseases and their management. With an impact factor reflective of its growing influence—ranking Q3 in Hepatology for the year 2023 and holding the 49th position out of 82 in Scopus Medicine Hepatology ranks—this publication underscores the significance of innovative research in this specialized domain. While it currently operates through a subscription model rather than open access, it bridges the gap in hepatological literature by featuring a diverse array of scholarly articles, case reports, and reviews from 2015 to 2024. Researchers and health professionals alike will find valuable insights that can enhance clinical practice and inform future studies, solidifying its importance in the hepatology community.

Metrics 2024

SCIMAGO Journal Rank0.48
Journal Impact Factor1.50
Journal Impact Factor (5 years)1.90
H-Index20
Journal IF Without Self1.50
Eigen Factor0.00
Normal Eigen Factor0.17
Influence0.42
Immediacy Index0.40
Cited Half Life3.80
Citing Half Life6.90
JCI0.32
Total Documents331
WOS Total Citations524
SCIMAGO Total Citations1254
SCIMAGO SELF Citations39
Scopus Journal Rank0.48
Cites / Document (2 Years)1.54
Cites / Document (3 Years)1.72
Cites / Document (4 Years)1.98

Metrics History

Rank 2024

Scopus

Hepatology in Medicine
Rank #49/82
Percentile 40.24
Quartile Q3

IF (Web Of Science)

GASTROENTEROLOGY & HEPATOLOGY
Rank 107/143
Percentile 25.50
Quartile Q3

JCI (Web Of Science)

GASTROENTEROLOGY & HEPATOLOGY
Rank 106/143
Percentile 25.87
Quartile Q3

Quartile History

Similar Journals

Clinical and Experimental Gastroenterology

Transforming clinical practices with rigorous gastroenterological findings.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7023Frequency: 1 issue/year

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.

HPB

Pioneering research for better liver health.
Publisher: ELSEVIER SCI LTDISSN: 1365-182XFrequency: 12 issues/year

HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.

Liver Cancer

Exploring innovative treatments and strategies for liver cancer.
Publisher: KARGERISSN: 2235-1795Frequency: 6 issues/year

Liver Cancer is a premier, peer-reviewed journal dedicated to the comprehensive study and advancement of knowledge surrounding liver neoplasms. Published by KARGER and headquartered in Switzerland, this journal has been an open-access platform since 2012, providing researchers with invaluable insights into the rapidly evolving field of hepatology and oncology. With an impressive impact factor that places it in the Q1 category for both Hepatology and Oncology in 2023, Liver Cancer stands out as a high-impact conduit for groundbreaking research, ranking #19 out of 404 in Medicine _ Oncology and #6 out of 82 in Medicine _ Hepatology according to Scopus. Researchers, practitioners, and students are encouraged to engage with the journal's content, which encompasses clinical studies, basic research, and reviews that contribute significantly to understanding liver cancer dynamics, diagnosis, and treatment strategies. This journal not only facilitates the dissemination of knowledge but also fosters collaboration in a well-established and impactful global scientific community.

Journal of Hepatocellular Carcinoma

Empowering researchers in the fight against liver cancer.
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

The Journal of Hepatocellular Carcinoma is a pivotal open-access publication dedicated to advancing the field of hepatocellular carcinoma research. Published by DOVE MEDICAL PRESS LTD since 2014, this journal seeks to disseminate high-quality articles that explore innovative treatments, clinical trials, and emerging research in the context of liver cancer. With its ISSN: N/A and E-ISSN: 2253-5969, the journal is optimized for a global audience, ensuring accessibility to a broad spectrum of researchers, healthcare professionals, and students engaged in oncology and hepatology. While its Scopus ranking places it in the lower quartiles of the respective fields, the journal continues to strive for growth and visibility in a rapidly evolving landscape. The Journal of Hepatocellular Carcinoma is an essential resource for anyone seeking to enhance their understanding of liver diseases and contribute to the fight against hepatocellular carcinoma.

Hepatology International

Connecting experts to revolutionize liver health.
Publisher: SPRINGERISSN: 1936-0533Frequency: 4 issues/year

Hepatology International is a premier academic journal dedicated to advancing the field of liver research and hepatology. Published by SPRINGER, this journal boasts a prestigious Q1 ranking in Hepatology as of 2023, underscoring its commitment to high-quality research dissemination. The journal’s scope encompasses a wide range of topics related to liver disease, including clinical, translational, and basic science studies. With its impact factor reflecting its relevance and influence in the field, Hepatology International serves as an essential resource for researchers, clinicians, and students aiming to keep abreast of the latest developments and breakthroughs. Though traditionally a subscription-based journal, it offers a vast array of insightful articles that contribute significantly to our understanding of hepatological conditions. The journal continues its trajectory of growth since its inception in 2008, anticipating a convergence of knowledge and innovation through to 2024. Located in the heart of New York City, this journal not only represents a crucial platform for global hepatology research but also fosters a collaborative community of experts dedicated to improving liver health worldwide.

Egyptian Journal of Dermatology and Venereology

Advancing the Science of Skin Health
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1110-6530Frequency: 2 issues/year

Egyptian Journal of Dermatology and Venereology is a premier peer-reviewed journal dedicated to advancing the fields of dermatology and venereology. Published by Wolters Kluwer Medknow Publications, this journal provides a vital platform for researchers, clinicians, and healthcare professionals to share cutting-edge research, case studies, and reviews that contribute to the understanding and treatment of skin and sexually transmitted diseases. With an ISSN of 1110-6530 and an E-ISSN of 2314-7407, the journal ensures global accessibility and visibility of its content, fostered by its commitment to high-quality publications. Although it operates with restricted access, the Egyptian Journal of Dermatology and Venereology remains an essential resource for practitioners and academics alike, supporting the dissemination of knowledge and innovation in skin health. Situated in Mumbai, India, the journal reflects a diverse pool of contributions that enrich our understanding of dermatological practices and principles on an international scale.

Journal of Clinical and Translational Hepatology

Exploring the frontiers of liver disease and treatment.
Publisher: XIA & HE PUBLISHING INCISSN: 2225-0719Frequency: 12 issues/year

Journal of Clinical and Translational Hepatology is an esteemed publication dedicated to advancing the field of hepatology through innovative research and clinical insights. Published by XIA & HE PUBLISHING INC, this journal connects researchers and healthcare professionals in the exploration of liver diseases and their management. With an impact factor that reflects its significant contribution to the discipline, the Journal holds a commendable Q2 classification in Hepatology as of 2023, and it ranks highly in both Gastroenterology and Hepatology categories on Scopus, positioning it within the top 80th percentile of its field. Although the journal is not open access, it provides its audience with invaluable information, encouraging collaboration that aims to translate clinical findings into transformative patient care. With a publication history spanning from 2013 to 2024, the Journal of Clinical and Translational Hepatology has established itself as a vital resource for researchers, clinicians, and students alike, making it a prominent voice in the hepatological community.

Hepatic Oncology

Transforming Knowledge into Practice in Hepatic Oncology
Publisher: FUTURE MEDICINE LTDISSN: 2045-0923Frequency: 4 issues/year

Hepatic Oncology is a premier Open Access journal published by Future Medicine Ltd that specializes in the critical intersection of hepatology and oncology. With a focus on advancing knowledge in the diagnosis and treatment of liver cancers, the journal provides a platform for innovative research, reviews, and clinical perspectives that serve as a valuable resource for researchers, clinicians, and students alike. Established in 2016 and evolving over the years, Hepatic Oncology underscores its commitment to accessible scientific communication, having transitioned to open access in 2018 to reach a broader audience. The journal holds a Q4 quartile ranking in the fields of hepatology and oncology for 2023, reflecting its emerging influence and role in contemporary research. Through high-quality articles and a focus on real-world applications, Hepatic Oncology aims to bridge gaps in knowledge while fostering collaboration among professionals dedicated to enhancing patient care in hepatic malignancies.

Hepatology Forum

Advancing liver health through innovative research.
Publisher: KARE PUBLISSN: 1307-5888Frequency: 4 issues/year

Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.

World Journal of Hepatology

Pioneering insights into hepatology for a healthier world.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1948-5182Frequency: 12 issues/year

World Journal of Hepatology is a premier academic journal dedicated to advancing the field of hepatology. Published by BAISHIDENG PUBLISHING GROUP INC, this journal serves as a crucial platform for disseminating innovative research findings and critical reviews from around the globe. With its ISSN 1948-5182 and E-ISSN 1948-5182, the journal has established a notable presence since its inception in 2009, covering a wide range of topics relevant to liver diseases, including but not limited to hepatitis, liver cancer, and metabolic liver disorders. Currently ranked 41/82 in the field of hepatology by Scopus, representing the 50th percentile, it has achieved a Q3 quartile ranking in the 2023 category, underscoring its growing influence in the medical community. With a commitment to open access for its readership, the World Journal of Hepatology enriches the global discourse on liver health and disease management, making it an essential resource for researchers, clinicians, and students alike.